Mortality in type 2 diabetes mellitus: Magnitude of the evidence from a systematic review and meta-analysis

British Journal of Diabetes and Vascular Disease

Volumn 13, Issue 4, 2013, Pages 192-207

  Nwaneri, Chukwuemeka ^a,b   Cooper, Helen ^a,c   Bowen Jones, David ^b  

^a UNIVERSITY OF CHESTER   (United Kingdom)

^b ARROWE PARK HOSPITAL   (United Kingdom)

^c ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

meta analysis; mortality rate; odds ratio; relative risk; systematic review; type 2 diabetes

Indexed keywords

INSULIN; METFORMIN; SULFONYLUREA;

ALCOHOL CONSUMPTION; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; FOLLOW UP; HUMAN; INSULIN TREATMENT; META ANALYSIS; MORTALITY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; PUBLISHING; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING; SYSTEMATIC REVIEW;

EID: 84882971398     PISSN: 14746514     EISSN: 17534305     Source Type: Journal    
DOI: 10.1177/1474651413495703     Document Type: Review

References (53)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diab Research Clin Pract. 2011 ; 94: 311-21
2. Fuller JH, Elford J, Goldblatt P, Adelstein AM. Diabetes Mortality: New light on an underestimated public health problem. Diabetologia. 1983 ; 24: 336-41
3. Guzder RN, Gatling W, Mullee MA, Byrne CD. Early Mortality from the time of diagnosis of Type 2 Diabetes: A 5-Year Prospective Cohort Study With A Local Age- And Sex-Matched Comparison Cohort. Diabet Med. 2007 ; 24: 1164-167
4. Gatling W, Guzder RN, Turnbull JC, et al. The Poole Diabetes Study: how many cases of type 2 diabetes are diagnosed each year during normal health care in a defined community?. Diabetes Res Clin Pract. 2001 ; 53: 107-12
5. Roglic G, Unwin N, Bennett PH, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005 ; 28: 2130-135
6. Diabetes UK. Diabetes in the UK. A report from Diabetes UK October 2004. http://www.library.nhs.uk/diabetes/ViewResource.aspx?resID=82430Accessed November 4, 2010.
7. At Risk: Developing chronic conditions later in life. Challenges for the 21st century.. 2000 ;: 4
8. Matsushima M, LaPorte RE, Maruyama M, Shimizu K, Nishimura R, Tajima N. Geographic variation in mortality among individuals with youth-onset diabetes across the world. DERI mortality Study Group. Diabetes Epidemiology Research International. Diabetologia. 1997 ; 40: 212-16
9. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001 ; 44: S14 - S21
10. Jeerakathil T, Johnson JA, Simpson SH, Majumdar SR. Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population based cohort study. Stroke. 2007 ; 38: 1739-43
11. Currie CJ, Poole CD, Gale EAM. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia. 2009 ; 52: 1766-77
12. Pollack M, Russell-Jones D. Insulin analogues and cancer risk: cause for concern or cause celebre?. Int J Clin Pract. 2010 ; 64: 628-36
13. Centre for Research and Development Report. Undertaking Systematic Reviews of Research on Effectiveness CRD's Guidance for those Carrying Out or Commissioning Reviews. CRD Report2001; 4 (2nd Edition). http://www.york.ac.uk/ search/?q=Undertaking+systematic+reviews+of+research+on+effectiveness& client=yorkweb&output=xml-no-dtd&proxystylesheet=yorkweb&site= crd-main. Accessed October 20, 2010.
14. Moher D, Pham B, Klassen TP, et al. What contributions do languages other than English make on the results of meta-analyses?. J Clin Epidemiol. 2000 ; 53: 964-72
15. Juni P, Holenstein F, Sterne J, et al. Direction and impact of language bias in meta-analyses of controlled trials: Empirical study. Int J Epidemiol. 2002 ; 31: 115-23
16. Loveman E, Cave C, Green C, et al. The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation. Health Technol Assess. 2003 ; 7: 1-211
17. Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Ann Intern Med. 2009 ; 151: 264-9
18. Al-Delaimy WK, Willett WC, Manson JE, et al. Smoking and mortality among women with type 2 diabetes: The Nurses' Health Study Cohort. Diabetes Care. 2001 ; 24: 2043-8
19. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: A population-based study of 13 000 men and women with 20 years of follow-up. Arch Intern Med. 2004 ; 164: 1422-6
20. Balkau B, Eschwège E, Papoz L, et al. Risk factors for early death in non-insulin dependent diabetes and men with known glucose intolerance status. BMJ. 1993 ; 307: 295-9
21. Behar S, Boyko V, Reicher-Reiss H, Goldbourt U. Ten-Year Survival After Acute Myocardial Infarction: Comparison Of Patients With And Without Diabetes. Am Heart J. 1997 ; 133: 290-6
22. Chaturvedi N, Jarrett J, Morrish N, et al. Differences In Mortality And Morbidity In African Caribbean And European People With Non-Insulin Dependent Diabetes Mellitus: Results Of 20 Year Follow Up Of A London Cohort Of A Multinational Study. BMJ. 1996 ; 313: 848-2
23. Gall M, Borch-Johnsen K, Hougaard P, et al. Albuminuria And Poor Glycemic Control Predict Mortality In NIDDM. Diabetes. 1995 ; 44: 1303-9
24. Hänninen J, Takala J, Keinänen-Kiukaanniemi S. Albuminuria and other risk factors for mortality in patients with non-insulin-dependent diabetes mellitus aged under 65 years: a population-based prospective 5-year study. Diabetes Res Clin Pract. 1999 ; 43: 121-6
25. Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001 ; 161: 1717-23
26. Mazza A, Zamboni S, Rizzato E, et al. Serum uric acid shows a J-shaped trend with coronary mortality in non-insulin-dependent diabetic elderly people. The CArdiovascular STudy in the ELderly (CASTEL). Acta Diabetol. 2007 ; 44: 99-105
27. Katakura M, Naka M, Kondo T, et al. Normal mortality in the elderly with diabetes under strict glycemic and blood pressure control: outcome of 6-year prospective study. Diabetes Res Clin Pract. 2007 ; 78: 108-14
28. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care. 1993 ; 16: 996-1003
29. O'Connor PJ, Crabtree BF, Nakamura RM. Mortality experience of Navajos with type 2 diabetes mellitus. Ethn Health. 1997 ; 2: 155-62
30. Olsson J, Lindberg G, Gottsäter M, et al. Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study. Diabetologia. 2000 ; 43: 558-60
31. Ostgren CJ, Lindblad U, Melander A, Rastam L. Survival In Patients With Type 2 Diabetes In A Swedish Community: Skaraborg Hypertension And Diabetes Project. Diabetes Care. 2002 ; 25: 1297-302
32. Sawicki PT, Kiwitt S, Bender R, Berger M. The Value of QT-Interval Dispersion For Identification Of Total Mortality Risk In Non-Insulin-Dependent Diabetes Mellitus. J Intern Med. 1998 ; 243: 49-56
33. Siscovick DS, Sotoodehnia N, Rea TD, et al. Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community. Rev Endocr Metab Disord. 2010 ; 11: 53-9
34. Valdés S, Botas P, Delgado E, Díaz Cadórniga F. Mortality risk in Spanish adults with diagnosed diabetes, undiagnosed diabetes or pre-diabetes. The Asturias study 1998-2004. Rev Esp Cardiol. 2009 ; 62: 528-34
35. Valmadrid CT, Klein R, Moss SE, Klein BEK. The Risk Of Cardiovascular Disease Mortality Associated With Microalbuminuria And Gross Proteinuria In Persons With Older-Onset Diabetes Mellitus. Arch Intern Med. 2000 ; 160: 1093-100
36. Vilbergsson S, Sigurdsson G, Sigvaldason H, Sigfusson N. Coronary heart disease mortality amongst non-insulin-dependent diabetic subjects in Iceland: the independent effect of diabetes. The Reykjavik Study 17-year follow-up. J Intern Med. 1998 ; 244: 309-16
37. Collins VR, Dowse GK, Ram P, et al. Non-insulin-dependent diabetes and 11-year mortality in Asian Indian and Melanesian Fijians. Diabet Med. 1996 ; 13: 125-32
38. Croxson SCM, Price DE, Burden M, Jagger C, Burden AC. Mortality of elderly people with diabetes. Diabet Med. 1994 ; 11: 250-2
39. Diem P, Deplazes M, Fajfr R, et al. Effects Of Alcohol Consumption On Mortality In Patients With Type 2 Diabetes Mellitus. Diabetologia. 2003 ; 46: 1581-5
40. Eliasson M, Talbäck M, Rosén M. Improved survival in both men and women with diabetes between 1980 and 2004-a cohort study in Sweden. Cardiovasc Diabetol. 2008 ; 7: 32
41. Florkowski CM, Scott RS, Coope PA, Moir CL. Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study. Diabetes Res Clin Pract. 2001 ; 53: 113-20
42. Gagliardino JJ, Werneke U, Olivera EM, et al. Characteristics, clinical course, and in-hospital mortality of non-insulin-dependent diabetic and non-diabetic patients with acute myocardial infarction in Argentina. J Diabetes Complications. 1997 ; 11: 163-71
43. Grauw WJC, van de Lisdonk EH, van den Hoogen HJM, van Weel C. Cardiovascular morbidity and mortality in type 2 diabetic patients: a 22-year historical cohort study in Dutch general practice. Diabet Med. 1995 ; 12: 117-22
44. Gu K, Cowie C, Harris M. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care. 1998 ; 21: 1138-45
45. Mannucci E, Monami M, Masotti G, Marchionni N. All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides. Diabetes Metab Res Rev. 2004 ; 20: 44-7
46. Sievers ML, Nelson RG, Knowler WC, Bennett PH. Impact of NIDDM on mortality and causes of death in Pima Indians. Diabetes Care. 1992 ; 15: 1541-9
47. Spijkerman AMW, Dekker JM, Nijpels G, et al. Impact Of Diabetes Duration And Cardiovascular Risk Factors On Mortality In Type 2 Diabetes: The Hoorn Study. Eur J Clin Invest. 2002 ; 32: 924-30
48. Tan HH, McAlpine RR, James P, et al. Diagnosis of type 2 diabetes at an older age: effect on mortality in men and women. Diabetes Care. 2004 ; 27: 2797-9
49. Barnett KN, McMurdo MET, Ogston SA, Morris AD. Mortality in people diagnosed with type 2 diabetes at an older age: a systematic review. Age and Aging. 2006 ; 5: 463-8
50. Dinneen SF, Gerstein HC. The Association of Microalbuminuria and Mortality in Non-Insulin-Dependent Diabetes Mellitus: A Systematic Overview of the Literature. Arch Intern Med. 1997 ; 157: 1413-8
51. Groeneveld Y, Petri H, Hermans J, Springer MP. Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review. Diabet Med. 1999 ; 16: 2-13
52. DuerdenM. What are Hazard ratios?London: Hayward Medical Communications, 2009. Available at www.whatsseries.co.ukAccessed October 20, 2011.
53. Gæde P, Lund-Andersen H, Parving H, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008 ; 358: 580-91